
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6493246
[patent_doc_number] => 20100093672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'USE OF S1P RECEPTOR MODULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/598771
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6308
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598771 | USE OF S1P RECEPTOR MODULATOR | Apr 30, 2008 | Abandoned |
Array
(
[id] => 5285579
[patent_doc_number] => 20090099254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Method and Kit for Regulation of Microvascular Tone'
[patent_app_type] => utility
[patent_app_number] => 12/104968
[patent_app_country] => US
[patent_app_date] => 2008-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6014
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12104968
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/104968 | Method and Kit for Regulation of Microvascular Tone | Apr 16, 2008 | Abandoned |
Array
(
[id] => 4613152
[patent_doc_number] => 07989421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Use of dimiracetam in the treatment of chronic pain'
[patent_app_type] => utility
[patent_app_number] => 12/450944
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5404
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450944 | Use of dimiracetam in the treatment of chronic pain | Apr 14, 2008 | Issued |
Array
(
[id] => 4887669
[patent_doc_number] => 20080262001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH IN THE LIVER FOLLOWING RESECTION'
[patent_app_type] => utility
[patent_app_number] => 12/102185
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13421
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102185
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102185 | AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH IN THE LIVER FOLLOWING RESECTION | Apr 13, 2008 | Abandoned |
Array
(
[id] => 6539074
[patent_doc_number] => 20100204338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'ANTI-ANGIOGENIC AGENTS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/595278
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 10132
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204338.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595278
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595278 | Method of using biothionol and biothionol-like compounds as anti-angiogenic agents | Apr 13, 2008 | Issued |
Array
(
[id] => 6350582
[patent_doc_number] => 20100249130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE'
[patent_app_type] => utility
[patent_app_number] => 12/595357
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 82521
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595357
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595357 | Biaryl compositions and methods for modulating a kinase cascade | Apr 13, 2008 | Issued |
Array
(
[id] => 4887671
[patent_doc_number] => 20080262003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'METHODS FOR TREATING NEOPLASIA WITH COMBINATION OF CHEMOTHERAPEUTIC AGENTS AND RADIATION'
[patent_app_type] => utility
[patent_app_number] => 12/102237
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9045
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102237 | Methods for treating neoplasia with combination of chemotherapeutic agents and radiation | Apr 13, 2008 | Issued |
Array
(
[id] => 10594431
[patent_doc_number] => 09315506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => '18F-labelled folates'
[patent_app_type] => utility
[patent_app_number] => 12/595301
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11322
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595301
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595301 | 18F-labelled folates | Apr 10, 2008 | Issued |
Array
(
[id] => 4955539
[patent_doc_number] => 20080188563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'BLOOD FLUIDITY IMPROVING AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/059547
[patent_app_country] => US
[patent_app_date] => 2008-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5179
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188563.pdf
[firstpage_image] =>[orig_patent_app_number] => 12059547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/059547 | BLOOD FLUIDITY IMPROVING AGENT | Mar 30, 2008 | Abandoned |
Array
(
[id] => 6321455
[patent_doc_number] => 20100113517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'METHOD FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONES'
[patent_app_type] => utility
[patent_app_number] => 12/594124
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13879
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594124 | METHOD FOR THE TREATMENT OF FABRY DISEASE USING PHARMACOLOGICAL CHAPERONES | Mar 27, 2008 | Abandoned |
Array
(
[id] => 4720161
[patent_doc_number] => 20080242684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'METHODS OF ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/058532
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19460
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242684.pdf
[firstpage_image] =>[orig_patent_app_number] => 12058532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/058532 | METHODS OF ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS | Mar 27, 2008 | Abandoned |
Array
(
[id] => 5474450
[patent_doc_number] => 20090247616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF ANXIETY'
[patent_app_type] => utility
[patent_app_number] => 12/055433
[patent_app_country] => US
[patent_app_date] => 2008-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15438
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12055433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/055433 | USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF ANXIETY | Mar 25, 2008 | Abandoned |
Array
(
[id] => 7751738
[patent_doc_number] => 08110571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-07
[patent_title] => 'Benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as c-MET inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/054719
[patent_app_country] => US
[patent_app_date] => 2008-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35527
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/110/08110571.pdf
[firstpage_image] =>[orig_patent_app_number] => 12054719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/054719 | Benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as c-MET inhibitors | Mar 24, 2008 | Issued |
Array
(
[id] => 6618782
[patent_doc_number] => 20100324094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents'
[patent_app_type] => utility
[patent_app_number] => 12/532829
[patent_app_country] => US
[patent_app_date] => 2008-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18049
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532829
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532829 | Conformationally restrained epothilone analogues as anti-leukemic agents | Mar 19, 2008 | Issued |
Array
(
[id] => 4740579
[patent_doc_number] => 20080234232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Methods and compositions for targeting AFAP'
[patent_app_type] => utility
[patent_app_number] => 12/077653
[patent_app_country] => US
[patent_app_date] => 2008-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234232.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077653
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077653 | Methods and compositions for targeting AFAP | Mar 19, 2008 | Abandoned |
Array
(
[id] => 4740633
[patent_doc_number] => 20080234286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'STABLE AMORPHOUS IMATINIB MESYLATE AND PRODUCTION PROCESS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/051597
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3882
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234286.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051597 | STABLE AMORPHOUS IMATINIB MESYLATE AND PRODUCTION PROCESS THEREFOR | Mar 18, 2008 | Abandoned |
Array
(
[id] => 4740591
[patent_doc_number] => 20080234244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'CUCURBITACIN B AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/051461
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234244.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051461 | CUCURBITACIN B AND USES THEREOF | Mar 18, 2008 | Abandoned |
Array
(
[id] => 6320618
[patent_doc_number] => 20100113406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'USE OF GLUCOCORTICOIDS FOR TREATMENT OF CONGESTIVE HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/449904
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7530
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12449904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449904 | USE OF GLUCOCORTICOIDS FOR TREATMENT OF CONGESTIVE HEART FAILURE | Mar 13, 2008 | Abandoned |
Array
(
[id] => 4823418
[patent_doc_number] => 20080227841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION'
[patent_app_type] => utility
[patent_app_number] => 12/048178
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6140
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227841.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048178 | INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION | Mar 12, 2008 | Abandoned |
Array
(
[id] => 5509224
[patent_doc_number] => 20090082431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/044870
[patent_app_country] => US
[patent_app_date] => 2008-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30921
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082431.pdf
[firstpage_image] =>[orig_patent_app_number] => 12044870
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/044870 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | Mar 6, 2008 | Abandoned |